207 related articles for article (PubMed ID: 36502328)
21. CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease.
Hermann P; Romero C; Schmidt C; Reis C; Zerr I
PLoS One; 2014; 9(8):e105000. PubMed ID: 25147945
[TBL] [Abstract][Full Text] [Related]
22. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
23. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
[TBL] [Abstract][Full Text] [Related]
24. Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
Dewenter A; Jacob MA; Cai M; Gesierich B; Hager P; Kopczak A; Biel D; Ewers M; Tuladhar AM; de Leeuw FE; Dichgans M; Franzmeier N; Duering M;
Brain; 2023 Feb; 146(2):678-689. PubMed ID: 35859352
[TBL] [Abstract][Full Text] [Related]
25. Brain amyloid β, cerebral small vessel disease, and cognition: A memory clinic study.
Saridin FN; Hilal S; Villaraza SG; Reilhac A; Gyanwali B; Tanaka T; Stephenson MC; Ng SL; Vrooman H; van der Flier WM; Chen CLH
Neurology; 2020 Nov; 95(21):e2845-e2853. PubMed ID: 33046617
[TBL] [Abstract][Full Text] [Related]
26. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
[TBL] [Abstract][Full Text] [Related]
27. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
Drake JD; Chambers AB; Ott BR; Daiello LA;
J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
[TBL] [Abstract][Full Text] [Related]
28. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
29. Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease.
Chong JR; Hilal S; Ashton NJ; Karikari TK; Reilhac A; Vrooman H; Schöll M; Zetterberg H; Blennow K; Chen CP; Lai MKP
Alzheimers Dement (Amst); 2023; 15(1):e12396. PubMed ID: 36994314
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
31. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
32. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
33. Cerebrovascular disease promotes tau pathology in Alzheimer's disease.
Laing KK; Simoes S; Baena-Caldas GP; Lao PJ; Kothiya M; Igwe KC; Chesebro AG; Houck AL; Pedraza L; Hernández AI; Li J; Zimmerman ME; Luchsinger JA; Barone FC; Moreno H; Brickman AM;
Brain Commun; 2020; 2(2):fcaa132. PubMed ID: 33215083
[TBL] [Abstract][Full Text] [Related]
34. White Matter Free Water Outperforms Cerebral Small Vessel Disease Total Score in Predicting Cognitive Decline in Persons with Mild Cognitive Impairment.
Zhu Z; Zeng Q; Zhang R; Luo X; Li K; Xu X; Zhang M; Yang Y; Huang P;
J Alzheimers Dis; 2022; 86(2):741-751. PubMed ID: 35124653
[TBL] [Abstract][Full Text] [Related]
35. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.
Guo T; Landau SM; Jagust WJ;
Alzheimers Res Ther; 2021 Oct; 13(1):174. PubMed ID: 34654465
[TBL] [Abstract][Full Text] [Related]
36. Association of inflammatory markers with cerebral small vessel disease in community-based population.
Jiang L; Cai X; Yao D; Jing J; Mei L; Yang Y; Li S; Jin A; Meng X; Li H; Wei T; Wang Y; Pan Y; Wang Y
J Neuroinflammation; 2022 May; 19(1):106. PubMed ID: 35513834
[TBL] [Abstract][Full Text] [Related]
37. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
[TBL] [Abstract][Full Text] [Related]
38. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
39. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans.
Habes M; Pomponio R; Shou H; Doshi J; Mamourian E; Erus G; Nasrallah I; Launer LJ; Rashid T; Bilgel M; Fan Y; Toledo JB; Yaffe K; Sotiras A; Srinivasan D; Espeland M; Masters C; Maruff P; Fripp J; Völzk H; Johnson SC; Morris JC; Albert MS; Miller MI; Bryan RN; Grabe HJ; Resnick SM; Wolk DA; Davatzikos C;
Alzheimers Dement; 2021 Jan; 17(1):89-102. PubMed ID: 32920988
[TBL] [Abstract][Full Text] [Related]
40. The Influence of Cerebral Small Vessel Disease on Static and Dynamic Functional Network Connectivity in Subjects Along Alzheimer's Disease Continuum.
Li K; Fu Z; Luo X; Zeng Q; Huang P; Zhang M; Vince CD
Brain Connect; 2021 Apr; 11(3):189-200. PubMed ID: 33198482
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
